WIRB-Copernicus Group Thought Leaders to Give Informed Consent Presentations at the Northwest Association for Biomedical Research Conference

Meeting will address the challenges of achieving informed consent in clinical research for both investigators and the ethics review community

PRINCETON, N.J., July 23, 2015 – WIRB-Copernicus Group® (WCG™), the world’s largest provider of regulatory and ethical review services and software to support clinical research, announced today that two of its thought leaders will be participating in panel discussions at the Northwest Association for Biomedical Research (NWABR) Conference being held on July 23 in Seattle, WA. This conference, which is co-presented by NWABR and Quorum Review IRB, is focused on “Revolutionizing Informed Consent.”

“It is WCG’s mission to protect human subjects in clinical research. Ensuring that those subjects fully understand the research protocol and all aspects of their participation in the study is an essential part of our work,” said WCG Chief Compliance Officer and Co-chair of the SACHRP Advisory Committee David Forster, JD, MA, CIP. “We are proud to participate in this conference and support NWABR’s efforts to educate industry professionals and ensure that the consent process advances alongside clinical research.”

WCG Vice President of Quality Management at Copernicus Group IRB and SACHRP Subpart A Subcommittee Co-chair David Borasky MPH, CIP will provide pertinent advice during the session entitled: “Recommendations for Improving Informed Consent: Recent Agency Guidance and Hot Topics” from 8:45-10:15 a.m. His co-presenters will be Leonard Sacks, MD, associate director for clinical methodology at the Office of Medical Policy, FDA; Cheryl Grandinetti, PharmD, health science policy analyst at the Office of Medical Policy, FDA; and Zachary Hallinan, director of patient communication and engagement programs at the Center for Information and Study on Clinical Research Participation (CISCRP).

Mr. Forster will participate in the panel discussion entitled: “Special Considerations Regarding Adults and Pediatric Populations” from 10:45 a.m. – 12:15 p.m. His co-presenters will be Douglas Diekema, MD, MPH, attending physician and IRB committee chair at Seattle Children’s Hospital, director of education at the Treuman Katz Center for Pediatric Bioethics, and professor of pediatrics at the University of Washington; and Ran Goldman, MD, IRB board member at Quorum Review IRB, professor of pediatrics at the University of British Columbia, head of translational therapeutics at BC Children’s Hospital, and director of PRETx.org.

For further information about this conference, please visit http://conferences.quorumreview.com/nwabr-revolutionizing-informed-consent-conference.

About WIRB-Copernicus Group
WIRB-Copernicus Group (WCG) is the world’s largest provider of regulatory and ethical solutions for clinical research. The company provides Institutional Review Board (IRB) and Institutional Biosafety Committee (IBC) reviews, and Human Research Protection (HRP), Good Clinical Practice (GCP) and Biosafety consulting services. Its technology offerings include IRB workflow management solutions (IRBNet), clinical trial management software for sponsors and contract research organizations (ePharmaSolutions), and Part-11 compliant online learning solutions for research professionals (WCG Academy).

The pioneer of independent ethical oversight, WCG continues to drive progress in the clinical research space. WCG empowers clients to accelerate life-saving advancements, while ensuring that the risks of progress never outweigh the value of human life.

For more information, please visit www.wcgclinical.com or follow us on Twitter @WCGClinical.

Download the Press Release
[wpdm_package id=’2698′]